Strategy
The objectives of SPIDIA will be obtained by integrative research approaches and technologies, covered by the following activities each consisting of different workpackages
Evidence-based, international guidelines and quality-assurance schemes
This activity consists in three key actions: (i) evaluation of solutions developed by the consortium by using ISO-certified analysis platforms and ring-trials, (ii) writing of proposed guidelines and quality assurance schemes for the pre-analytical phase of combined classical and molecular diagnostics, (iii) discovery of quality assurance biomarkers to monitor the quality of biological samples easily and cost-effectively.
The results of the research carried out under activity 1, will be provided to CEN/TC 140 In vitro diagnostic medical devices as an input and a potential basis for technical work on European Standards, Technical Specifications or Technical Reports in the field of pre-analytical procedures.
Research leading to pre-analytical tools for molecular in vitro diagnostics and classical pathology
This activity is dedicated to the discovery and integration of breakthrough technologies that strengthen weak links in the pre-analytical phase of in vitro diagnostics. The results will allow the association of classical and molecular diagnostics. The work varies from the discovery of stabilisation technologies for tissues, blood, and non-invasive samples, such as swab samples to the integration of multiple pre-analytical steps into an automated workflow. Furthermore, this activity will evaluate and provide feedback encouraging improvement and innovation of guidelines and tools used for the discovery and validation of biomarkers.
Management, ethics and spreading of excellence
This activity will provide support and ethical rigour to the RTD and standardisation activities in SPIDIA. It also aims to connect the outputs of SPIDIA to information channels for end users of the standards (Activity 1) and scientific and technological discoveries (Activity 2) as well as the general public. Internal training activities and seminars will be organised for SPIDIA members, other training activities will also be open for the research community. A wide dissemination of the research outcomes to a broader public beyond the research community will be supported through dissemination and knowledge transfer. Special attention will be given to the ethical, legal and societal aspects associated with the research with human biological samples.
About the Project
Newsletter
Subscribe to our newsletter to receive latest news about the project
Contact Us
Visit our contact form to contact SPIDIA and to submit comments and questions about this website.
